Search - tctmd.com

Displaying 21 - 40 of 86

Sort: Relevancy | Date

Blood pressure and MACE reductions after renal denervation: 3-year GSR results

Presentation EuroPCR 2022

Blood pressure and MACE reductions after renal denervation: 3-year GSR results

Presenter: Felix Mahfoud

May 20, 2022

Distal Radial Access Doesn’t Lower Risk of Occlusion: DISCO RADIAL

News Conference News EuroPCR 2022

Distal Radial Access Doesn’t Lower Risk of Occlusion: DISCO RADIAL

Michael O'Riordan

May 19, 2022

TriCLASP: Tricuspid Repair With Pascal Safe, Effective at 30 days

News Conference News EuroPCR 2022

TriCLASP: Tricuspid Repair With Pascal Safe, Effective at 30 days

Yael L. Maxwell

May 19, 2022

MitraClip Helps for Atrial Functional MR: MITRA-TUNE

News Conference News EuroPCR 2022

MitraClip Helps for Atrial Functional MR: MITRA-TUNE

Michael O'Riordan

May 19, 2022

Intravascular Imaging Boosts Outcomes in Left Main PCI ROLEX

News Conference News EuroPCR 2022

Intravascular Imaging Boosts Outcomes in Left Main PCI: ROLEX

Michael O'Riordan

May 18, 2022

Shorter DAPT Sufficient Even in Complex HBR Patients: MASTER DAPT

News Conference News EuroPCR 2022

Shorter DAPT Sufficient Even in Complex HBR Patients: MASTER DAPT

Yael L. Maxwell

May 17, 2022

Registry Data Hint at MACE Benefit with Renal Denervation

News Conference News EuroPCR 2022

Registry Data Hint at MACE Benefit With Renal Denervation

Michael O'Riordan

May 17, 2022

Patient-Level Pooled Analysis of Ultrasound RDN in RADIANCE-HTN SOLO and TRIO

Presentation EuroPCR 2022

Patient-Level Pooled Analysis of Ultrasound RDN in RADIANCE-HTN SOLO and TRIO

Presenter: Ajay J. Kirtane, Michel Azizi

May 17, 2022

Provisional Stenting Noninferior to Planned Two-Stent Strategy for Left Main Disease: EBC MAIN

News Conference News EuroPCR 2021

Provisional Stenting Noninferior to Planned Two-Stent Strategy for Left Main Disease: EBC MAIN

May 21, 2021

Tricuspid Trio: TRISCEND, CLASP TR, and TriBAND Studies Show Advances

News Conference News EuroPCR 2021

Tricuspid Trio: TRISCEND, CLASP TR, and TriBAND Studies Show Advances

May 21, 2021

Good TAVI Results Seen Bicuspid Aortic Stenosis TVT Registry.PNG

News Conference News EuroPCR 2021

Good TAVI Results Seen in Bicuspid Aortic Stenosis: TVT Registry

May 20, 2021

Complete 2-Year Data From Evolut Low-Risk Trial ‘Reassuring’ for TAVI

News Conference News EuroPCR 2021

Complete 2-Year Data From Evolut Low-Risk Trial ‘Reassuring’ for TAVI

Yael L. Maxwell

May 19, 2021

The Skinny on Ultrathin DES: Meta-analysis Shows Some Long-term Advantages

News Conference News EuroPCR 2021

The Skinny on Ultrathin DES: Meta-analysis Shows Some Long-term Advantages

May 19, 2021

Elective Revascularization, Better Long-term Survival: Meta-analysis

News Conference News EuroPCR 2021

Elective Revascularization, Better Long-term Survival: Meta-analysis

Michael O'Riordan

May 18, 2021

No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

News Conference News EuroPCR 2020

No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

Michael O'Riordan

June 26, 2020

New Data Add to Resurgent Renal Denervation Field

News Conference News EuroPCR 2020

New Data Add to Resurgent Renal Denervation Field

June 26, 2020

Small Study Lends Further Support to the Anti-arrhythmic Potential of Renal Denervation

News Conference News EuroPCR 2019

Small Study Lends Further Support to the Antiarrhythmic Potential of Renal Denervation

June 06, 2019

Cardiogenic Shock Old and New: IABPs a Thing of the Past and ECMO Under Study

News Conference News EuroPCR 2019

Cardiogenic Shock Old and New: IABPs a Thing of the Past and ECMO Under Study

June 05, 2019

ROBOT-ACS: Real-World Data Reiterate Ticagrelor’s Safety

News Conference News EuroPCR 2019

ROBOT-ACS: Real-World Data Reiterate Ticagrelor’s Safety

May 31, 2019

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

News Conference News EuroPCR 2019

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

Michael O'Riordan

May 27, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.